Answers are grounded in this paper and cite their sources.
Background: We examined factors associated with expedited partner therapy (EPT) uptake and clearance of Chlamydia trachomatis (CT) and/or Neisseria gonorrhoeae (NG) among women taking HIV pre-exposure prophylaxis (PrEP) in Kenya. Methods: We conducted a nested analysis of cisgender women enrolled in the dPEP Kenya Study (N=449) who tested positive for CT and/or NG during quarterly testing over one year. Following each positive test, participants received treatment, were offered optional EPT, and returned for a test of cure 2–4 weeks later. Baseline characteristics were compared between participants with and without EPT uptake using chi-square tests. Generalized estimating equation models assessed visit-level correlates of EPT uptake and test-of-cure outcomes while accounting for repeated infections over time. Results: Among 140 participants with CT or NG infection at 209 study visits, 75% (n=105) accepted EPT at least once. Women who accepted EPT were more likely to have an independent income (61.9% p=0.018) and report recent transactional sex (54.3%, p=0.032). At the visit level, having a primary sex partner was positively associated with EPT uptake (OR=2.17, 95% CI=1.01–4.65, p=0.047). Intimate partner violence was associated with lower EPT uptake in multivariable analysis (OR=0.23, 95% CI=0.06–0.95, p=0.042). EPT uptake was not significantly associated with a negative test-of-cure result (OR=2.42, 95% CI=0.89–6.56, p=0.082). Conclusions: EPT uptake was high among women taking PrEP in Kenya. While partner and relationship factors influenced uptake, EPT was not significantly associated with STI clearance at test of cure.
No takes yet. Share an insight, caveat, or question.
Juma et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: